Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Entera Bio Ltd. (ENTX)
Price$2.96Cached quote
Net income
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42,000 | $181,000 | $0 | $134,000 | $571,000 | $365,000 | $236,000 | $500,000 | — | — |
| Gross profit | $0 | $9,000 | $0 | $33,000 | $198,000 | $65,000 | $26,000 | — | — | — |
| Gross margin | 0.00% | 4.97% | — | 24.63% | 34.68% | 17.81% | 11.02% | — | — | — |
| Research & development | $6.0M | $4.5M | $4.5M | $5.8M | $6.8M | $6.4M | $7.2M | $8.5M | $2.8M | $2.6M |
| Operating expenses | $11.5M | $9.6M | $8.9M | $13.1M | $12.4M | $11.2M | $11.5M | — | — | — |
| Operating income | −$11.5M | −$9.6M | −$8.9M | −$13.0M | −$12.2M | −$11.2M | −$11.5M | −$10.9M | −$11.3M | −$5.4M |
| Operating margin | −27,450.00% | −5,295.58% | — | −9,714.18% | −2,139.58% | −3,059.73% | −4,853.39% | −2,172.20% | — | — |
| EBITDA | −$11.5M | −$9.5M | −$8.8M | −$13.0M | −$12.2M | −$10.9M | −$11.2M | −$10.8M | −$11.3M | −$5.3M |
| EBITDA margin | −27,378.57% | −5,270.17% | — | −9,666.42% | −2,130.30% | −2,998.08% | −4,752.54% | −2,161.40% | — | — |
| Net income | −$11.4M | −$9.5M | −$8.9M | −$13.1M | −$12.2M | −$11.2M | −$10.8M | −$10.3M | −$11.2M | −$1.2M |
| Net profit margin | −27,235.71% | −5,271.27% | — | −9,754.48% | −2,134.33% | −3,072.88% | −4,574.15% | −2,060.80% | — | — |
| Basic EPSper basic share | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.67 | $0.89 | $1.30 | $2.49 | $0.27 |
| Diluted EPSper diluted share | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.67 | $0.89 | $1.31 | $2.49 | $0.78 |
Owners
Reported shareholders
11.93%of listed shares
Knoll Capital Management, LLC5.88M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Knoll Capital Management, LLC | 11.93%5.88M shares |
BVF INC/IL | 4.92%2.43M shares |
Siren, L.L.C. | 1.49%736.46K shares |
Toledano Miranda Jayne | ≈0.87%426.58K shares |
RENAISSANCE TECHNOLOGIES LLC | 0.75%368.85K shares |
LIEBERMAN GERALD M | ≈0.70%344.65K shares |
Parkman Healthcare Partners LLC | 0.56%274.5K shares |
PNC Financial Services Group, Inc. | 0.55%273.03K shares |
Seven Fleet Capital Management LP | 0.39%191.35K shares |
Burshtein Gregory | ≈0.38%189.03K shares |
Ellis Sean | ≈0.38%188.1K shares |
Yaacov-Garbeli Dana | ≈0.35%171.44K shares |
Galitzer Hillel | ≈0.33%163.57K shares |
Malca Yonatan | ≈0.16%77.42K shares |
OSTROV GERALD M | ≈0.15%75.66K shares |
HighTower Advisors, LLC | 0.15%74.57K shares |
HRT FINANCIAL LP | 0.15%72.49K shares |
Schonfeld Strategic Advisors LLC | 0.12%58.87K shares |
TWO SIGMA SECURITIES, LLC | 0.10%48.59K shares |
SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | 0.10%47.33K shares |
Percentages use 49.29M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 9, 2026Form 4 | Germano Geno JDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 20.0K | $1.30 | $26.0K | 40.0K |
| Mar 5, 2026Form 4 | Ellis SeanDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 10.0K | $1.23 | $12.3K | 188.1K |
| Feb 12, 2026Form 4 | Rubin Steven DDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 5.0K | $1.49 | $7.5K | 15.0K |
| Feb 10, 2026Form 4 | Taitel HayaDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 7.5K | $1.48 | $11.1K | — |
| Feb 10, 2026Form 4 | Germano Geno JDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 20.0K | $1.49 | $29.8K | — |